Haemocomplettan® P – Human Fibrinogen

Haemocomplettan is used for treatment and prophylaxis of bleeding in patients with:

A. Congenital hypo-, dys- or afibrinogenaemia

B. Acquired hypofibrinogenaemia resulting from:
• disorders of synthesis in cases of severe liver parenchyma damage
• increased intravascular consumption e.g. as a result of disseminated intravascular coagulation, hyperfibrinolysis
• increased blood loss

The most important clinical pictures associated with a defibrination syndrome are:
Obstetrical complications, acute leukaemia especially promyelocytic leukaemia, liver cirrhosis, intoxications, extensive injuries, haemolysis after transfusion errors, operative interventions, infections, sepsis, all forms of shock as well as tumours especially in the lung, pancreas, uterus, and prostate.